Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients
Clinical trial NCT06800391 · RECRUITING
Trial details
- NCT number
- NCT06800391
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-22
- Primary completion
- 2027-11-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.